
    
      This is a prospective, multi-center, randomized, masked, vehicle-controlled, dose-escalation
      study that will include an observational (no intervention) sub-study. Up to 71 eligible
      subjects with moderate to severe corneal endothelial dystrophy (defined as Endothelial Cell
      Density < 2000 mm^2) in at least one eye will be enrolled and randomized in the main study.
      The Observational Sub-study will enroll approximately 25 to 50 subjects.
    
  